Omeprazole was found to suppress in vivo GBM development in AhR-expressing tumors, enhancing the repression of immune genes CXCL12, CXCR4, and MMP9, implicated notably in myeloid cells recruitment. This evidence concerns the gene AHR and glioblastoma.